ITP - IMMUNE THROMBOCYTOPENIA

Clinical trials for ITP - IMMUNE THROMBOCYTOPENIA explained in plain language.

Never miss a new study

Get alerted when new ITP - IMMUNE THROMBOCYTOPENIA trials appear

Sign up with your email to follow new studies for ITP - IMMUNE THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1

New combo therapy trial aims for better control of bleeding disorder

Disease control Not yet recruiting

This study is testing if adding a vitamin A-related drug (all-trans retinoic acid) to a standard platelet-boosting drug (avatrombopag) works better for controlling immune thrombocytopenia (ITP) than the standard drug alone. It will involve about 248 adults whose ITP did not fully…

Matched conditions: ITP - IMMUNE THROMBOCYTOPENIA

Phase: PHASE2, PHASE3 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated Mar 20, 2026 14:47 UTC

ITP - IMMUNE THROMBOCYTOPENIA

Get alerted when new ITP - IMMUNE THROMBOCYTOPENIA trials appear

New combo therapy trial aims for better control of bleeding disorder